Hani S Hafez

7PUBLICATIONS
13CO-AUTHORS
Neurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 26, 2026
Chitosan Nanoparticles Co-Encapsulating Selegiline Analogue and L-Tyrosine Mitigate Depression-Related Pathology and Cognitive Decline in Rats.

|May 13, 2026
Amelioration of 5-Fluorouracil-Induced Hepatorenal Toxicity by Epigallocatechin Gallate-Functionalized Selenium Nanoparticles: A Multi-Targeted Protective Approach.

|Apr 20, 2026
Development of a multi-targeted sulfonyl-bridged bisselenadiazole derivative as a potent EGFR/PI3K/AKT/mTOR modulator in lung adenocarcinoma.

|Sep 27, 2025
Correction: Awaji et al. Chemotherapeutic Activity of Imidazolium-Supported Pd(II) o-Vanillylidene Diaminocyclohexane Complexes Immobilized in Nanolipid as Inhibitors for HER2/neu and FGFR2/FGF2 Axis Overexpression in Breast Cancer Cells. Pharmaceuticals 2023, 16, 1711.

Aeshah A Awaji, Moustafa A Rizk, Raiedhah A Alsaiari

|Jun 18, 2025
Hybrid thiazolyl-benzylidene-phenol metal complexes as novel chemotherapeutic agents with anti-topoisomerase I activity in human breast carcinoma: synthesis, in vitro and in silico studies.

Ahmed M Alharbi, Mona Katary, Khulud M Alshehri

|Dec 23, 2023
Chemotherapeutic Activity of Imidazolium-Supported Pd(II) o-Vanillylidene Diaminocyclohexane Complexes Immobilized in Nanolipid as Inhibitors for HER2/neu and FGFR2/FGF2 Axis Overexpression in Breast Cancer Cells.

Aeshah A Awaji, Moustafa A Rizk, Raiedhah A Alsaiari

Pageof 2

Frequent Collaborators

5 joint publications

Reda F M Elshaarawy

2 joint publications

Moustafa A Rizk

2 joint publications

Ahlem Guesmi

2 joint publications

Naoufel Ben Hamadi